CompletedNot Applicable

Study Evaluating How Patients With Acute Coronary Syndrome Are Managed During 2 Years After Discharge

Argentina10,568 participantsStarted 2010-09

Plain-language summary

The aim of this international study is to describe the short- and long-term (i.e. up to 2 years following the index event) antithrombotic management patterns (AMPs) in patients hospitalized for acute coronary syndromes (ST segment elevation myocardial infarction (STEMI), Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS)), and to document the impact of AMPs in clinical outcomes, economic variables and quality of life in a 'real-life' setting and to compare these between sites, countries and regions.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of myocardial infarction or unstable angina * Hospitalized for the first time within 24 hours of onset of symptoms Exclusion Criteria: * Presence of any condition/circumstance which in the opinion of the investigator could significantly limit the complete follow up of the patient (e.g. tourist, non-native speaker or does not understand the local language, psychiatric disturbances) * Current participation in a clinical trial.

What they're measuring

Clinical outcomes (ischemic and bleeding) incidence and time to these clinical outcomes

Timeframe: Longitudinal during 2 years after index event (phone calls to the patients at 6 weeks and each 3 months after index event)

Trial details

NCT IDNCT01171404

SponsorAstraZeneca

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2013-03

View on ClinicalTrials.gov More ACS trials